They can modulate the retinal microenvironment by downregulating pro-inflammatory cytokines (IL-1β, TNF-α, VEGF), suppressing nitric oxide production, and reducing oxidative stress, collectively mitigating retinal degeneration. The gene discussed is IL1B; the disease is retinal degeneration.